Deadline: October 8, 2027

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. Offered by National Institutes of Health; applications due October 8, 2027.

Key Facts

Funder
National Institutes of Health
Award amount
Not specified by funder
Deadline
October 8, 2027
Geography
United States
Categories
Research
Status
Open

About This Grant

This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of...

Full requirements and application instructions: official listing.

Similar Open Grants

Deadlines Move. Your Search Shouldn't Start Over.

Get matched to open grants by eligibility and track every deadline in one workspace.